Kristina Gemzell-Danielsson Selected Research

Neoplasms (Cancer)

6/2022	Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.
1/2022	Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.
1/2022	Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
1/2019	Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA1-/2- carriers.
10/2018	Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
1/2018	Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
3/2007	Expression of aquaporin-1 in endometrial blood vessels in menorrhagia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristina Gemzell-Danielsson Research Topics

Disease

14	Pain (Aches) 11/2021 - 07/2004
11	Hemorrhage 01/2022 - 09/2003
7	Neoplasms (Cancer) 06/2022 - 03/2007
7	Incomplete Abortion 01/2022 - 07/2014
6	Infertility (Sterility) 10/2021 - 06/2009
6	Endometriosis 05/2021 - 01/2011
6	Amenorrhea 09/2020 - 11/2004
5	COVID-19 10/2022 - 10/2020
5	Menorrhagia 01/2021 - 01/2017
4	Ectopic Pregnancy 06/2022 - 06/2009
4	Leiomyoma (Uterine Fibroids) 09/2020 - 01/2013
3	Congenital heart block 01/2022 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
3	Uterine Rupture 11/2021 - 10/2016
3	Metrorrhagia (Spotting) 09/2020 - 01/2019
3	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 05/2013 - 04/2008
3	Abdominal Pain (Pain, Abdominal) 05/2011 - 07/2004
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2019
2	Uterine Hemorrhage (Uterine Bleeding) 11/2021 - 05/2008
2	Infections 11/2021 - 06/2015
2	Gynatresia 05/2021 - 01/2019
2	Adenomyosis 11/2020 - 10/2019
2	Venous Thromboembolism 11/2019 - 01/2019
2	Hyperplasia 01/2018 - 01/2012
2	Cicatrix (Scar) 10/2016 - 05/2008
2	Thromboembolism 07/2013 - 06/2013
2	Headache (Headaches) 06/2008 - 07/2004
1	Neonatal Systemic lupus erythematosus 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Atrioventricular Block 01/2022
1	Uterine Perforation 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Depressive Disorder (Melancholia) 01/2021
1	Anemia 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Cysts 10/2020
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 11/2019
1	Dysmenorrhea (Menstrual Pain) 10/2019

Drug/Important Bio-Agent (IBA)

15	Misoprostol (Cytotec)FDA LinkGeneric 01/2022 - 09/2003
10	Contraceptive Agents (Contraceptives)IBA 01/2021 - 03/2012
9	Mifepristone (RU 486)FDA Link 01/2022 - 09/2003
8	Progestins (Progestagens)IBA 01/2022 - 07/2008
6	Levonorgestrel (Plan B)FDA LinkGeneric 01/2022 - 03/2012
4	Progesterone FDA LinkGeneric 01/2022 - 07/2008
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
3	Hormones (Hormone)IBA 06/2022 - 02/2020
3	Estrogens (Estrogen)FDA Link 01/2022 - 09/2016
3	AutoantibodiesIBA 01/2022 - 01/2020
3	vilaprisanIBA 09/2020 - 01/2017
3	Pharmaceutical PreparationsIBA 02/2020 - 07/2004
2	ulipristal acetate FDA Link 01/2022 - 09/2020
2	Bromocriptine (Parlodel)FDA LinkGeneric 11/2020 - 10/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 07/2008
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2013
2	Analgesics (Analgesic Drugs)IBA 12/2014 - 11/2005
2	Cyproterone AcetateIBA 07/2013 - 06/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2011 - 04/2008
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	VitaminsIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	AuxilinsIBA 01/2022
1	Local AnestheticsIBA 11/2021
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 10/2021
1	Hexachlorobenzene (HCB)IBA 10/2021
1	thiamine triphosphorate (TTP)IBA 10/2021
1	Persistent Organic PollutantsIBA 10/2021
1	N 30IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	IronIBA 01/2021
1	SyndecansIBA 10/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2020
1	Syndecan-1 (Syndecan 1)IBA 10/2020
1	Proteoglycans (Proteoglycan)IBA 10/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2020
1	Interleukin-10 (Interleukin 10)IBA 02/2020
1	drospirenone FDA LinkGeneric 01/2020
1	Lidocaine (Xylocaine)FDA LinkGeneric 12/2019
1	KetorolacIBA 12/2019
1	ProlactinIBA 10/2019

Therapy/Procedure

8	Contraception (Birth Control) 01/2022 - 07/2008
4	Therapeutics 05/2021 - 06/2009
3	Induced Abortion (Induced Abortions) 10/2022 - 01/2021
3	Aftercare (After-Treatment) 01/2022 - 01/2019
3	Cesarean Section (Caesarean Section) 01/2018 - 05/2008
3	Catheters 01/2018 - 05/2011
2	Analgesia 12/2019 - 12/2014
2	Pain Management 12/2019 - 05/2008
2	Induced Labor 01/2018 - 10/2016
2	Intravaginal Administration 07/2004 - 09/2003
1	ANAVACYM protocol 06/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Anesthesia 11/2021
1	Hysterectomy 01/2021
1	Injections 11/2019
1	Hormonal Contraception 11/2019
1	Salpingo-oophorectomy 01/2019